Today, Micro-Invasive Glaucoma Surgery (MIGS) is an approved treatment method.
ELT (Excimer-Laser-Trabeculostomy) – the first micro-invasive procedure in glaucoma surgery since 1997 – is absolutely implant free.
The photoablative ExTra-Laser operates at a wavelength of 308 nm. It creates a direct connection between the front chamber and the Schlemm’s canal via a probe (FIDO Laser Applicator) in physical contact with the trabecular meshwork.
Due to the non-thermal ELT, the trabecular meshwork virtually does not show any tissue reactions activated postoperatively.
In the meantime, clinical data on micro-invasive ELT with up to eight years of follow-up are available, proving the long-term efficacy of ELT both as a stand-alone procedure and in combination with phacoemulsification.
The intraoperative possible observation of a slight reflux hemorrhage provides you with a quality criterion for the effective positioning of the fiber at the trabecular meshwork to create a passageway into Schlemm´s canal.
A minor reflux bleeding that can be observed intraoperatively provides you with a reliable quality criterion for the effective positioning of the fiber at the trabecular meshwork to open Schlemm’s canal.
ELT treats the problem of open-angle glaucoma exactly where it occurs by considerably increasing the permeability of the trabecular meshwork and – if compared to other treatment methods – at clearly low risk.